Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy

Not Applicable

Active, not recruiting

• Conditions: Brain Neoplasm; Recurrent Brain Neoplasm

• Registration Number: NCT01503086
• Lead Sponsor: Children's Oncology Group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12-30
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 71

Inclusion Criteria

Inclusion Criteria:<br><br> - Patient must be newly diagnosed or relapsed/progressed with a brain tumor that has<br> not previously been treated with CRT<br><br> - Note: COG therapeutic study participation is not required for ACCL10P1<br> enrollment<br><br> - Patient enrollment must occur within 4 calendar months following completion of CRT<br><br> - Reminder: after patient enrollment, baseline testing followed by randomization<br> must occur within 2-4 months after completion of CRT<br><br> - The patient must have an identified caregiver who is willing and able to oversee the<br> training practice during the intervention period (ie, for 5-9 weeks starting<br> approximately 3 months after completion of CRT)<br><br> - The patient must have access to a telephone and phone number where they can be<br> reached<br><br> - The patient and caregiver must have reading, speaking and listening comprehension of<br> English<br><br> - All patients and/or their parents or legal guardians must sign a written informed<br> consent (patient assent is also recommended when applicable according to each<br> institution's policy)<br><br> - All institutional, Food and Drug Administration (FDA), and National Cancer Institute<br> (NCI) requirements for human studies must be met<br><br>Exclusion Criteria:<br><br> - Patients with pontine glioma are not eligible<br><br> - Patients with an estimated survival of less than one year are not eligible<br><br> - Patients with a history of traumatic brain injury prior to tumor diagnosis are not<br> eligible<br><br> - Patients with a motor, visual, or auditory handicap that prevents computer use<br> (e.g., unresolved posterior fossa syndrome) are not eligible to participate in this<br> trial<br><br> - Patients with full-scale intelligence quotient (IQ) < 70 per previous testing OR<br> existing diagnosis of/educational classification as a student with an intellectual<br> disability are not eligible

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients with intervention compliance